Skip to main content
Premium Trial:

Request an Annual Quote

Warnex Lab Accreditation Renewed

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Warnex said on Monday that its Medical Laboratories division's accreditation has been renewed by the US healthcare accreditation organization COLA.

COLA initially gave its accreditation, which exceeds or meets requirements under the clinical laboratory improvement amendments (CLIA) standards, to the Canadian company in 2007.

The accreditation covers standards for quality in day-to-day operations, requires accuracy in performance and proficiency, and includes an on-site lab survey. Its Medical Laboratories division provides specialized testing and lab services for the healthcare and pharmaceutical industries.

Warnex has facilities in Laval and Blainville in Quebec and at Thunder Bay in Ontario.

COLA is a non-profit, physician-directed organization that has been approved by the US government and is sponsored by the American Academy of Family Physicians, the American Medical Association, and other organizations, said Warnex.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.